Capital Raising & Corporate Finance
Tariffs: CFOs Shift Costs To Customers
Ongoing trade tensions resulting from the Trump Administration’s stance on global tariffs continue to rattle companies and markets. Recent developments...
Capital Raising & Corporate Finance
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Capital Raising & Corporate Finance
Banks Rebrand DEI Programs
A rose by any other name might not be a rose if it refers to diversity, equity, and inclusion (DEI)...
Technology
The Space Boom Is Here
Falling costs, private investment, and new business opportunities are fueling a rapidly expanding space economy poised for major growth. ...
Sustainable Finance
Diverging Paths: Japan Embraces ESG As US Retreats
Political opposition stalls US momentum in green investing, while Japan takes the lead with GX bonds and a long-term financing...
Capital Raising & Corporate Finance
Capital Meets Conscience As Social Bonds Rise
Lenders are scaling up efforts to meet sustainable development targets, with capital directed toward healthcare, education, and essential infrastructure. Major...
Capital Raising & Corporate Finance
How CFOs Are Managing Geostrategic Risks
Global Finance: What are some of the most pressing geostrategic risk factors that companies should be concerned about in the...
Insurance
Aflac’s Brad Dyslin On Japan’s Investment Shifts, Tariffs, And Insurance M&As
Dyslin, Global CIO and President of Global Investments, discusses managing yen exposure, the role of private investments in the insurance...
Capital Raising & Corporate Finance
Aramco’s Dividend Strategy Reflects Shifting Energy Priorities
The oil giant cut its dividend to balance shareholder payouts with rising capital investments amid lower crude prices and evolving...
Capital Raising & Corporate Finance
Navigating The New Trade Order
As global trade fractures in 2025, companies face rising tariffs, supply chain turmoil, and shifting economic dynamics. Geopolitical pressures are...
Capital Raising & Corporate Finance
CFO Corner: Anne-Laure Autret-Cornet, OSE Immunotherapeutics
Since 2016, Anne-Laure Autret-Cornet has been the CFO of OSE Immunotherapeutics, a biotech dedicated to immuno-oncology and immuno-inflammation. The Nantes,...
Capital Raising & Corporate Finance
Forecasting Future Fraud: Q&A With Joanne Horton Of Warwick Business School
Global Finance: Can you briefly describe what your model does? Joanne Horton: Yes. We’ve got what we think is a...
Capital Raising & Corporate Finance
India: Shapoorji Pallonji Eyes Private Credit Deal
India’s Shapoorji Pallonji (SP) Group, a construction and real estate conglomerate, is negotiating with global private credit funds to raise...